Envestnet Asset Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,166
| Closed | -$163K | – | 4247 |
|
|
2024
Q2 | $163K | Sell |
12,166
-9,937
| -45% | -$133K | ﹤0.01% | 3982 |
|
|
2024
Q1 | $1.03M | Buy |
22,103
+4,325
| +24% | +$201K | ﹤0.01% | 3014 |
|
|
2023
Q4 | $1.2M | Buy |
17,778
+8,857
| +99% | +$599K | ﹤0.01% | 2811 |
|
|
2023
Q3 | $646K | Buy |
8,921
+3,265
| +58% | +$236K | ﹤0.01% | 3107 |
|
|
2023
Q2 | $421K | Buy |
5,656
+2,862
| +102% | +$213K | ﹤0.01% | 3299 |
|
|
2023
Q1 | $149K | Sell |
2,794
-553
| -17% | -$29.4K | ﹤0.01% | 3727 |
|
|
2022
Q4 | $226K | Buy |
3,347
+26
| +0.8% | +$1.76K | ﹤0.01% | 3611 |
|
|
2022
Q3 | $414K | Buy |
3,321
+1,243
| +60% | +$155K | ﹤0.01% | 3131 |
|
|
2022
Q2 | $198K | Buy |
2,078
+767
| +59% | +$73.1K | ﹤0.01% | 3609 |
|
|
2022
Q1 | $211K | Buy |
+1,311
| New | +$211K | ﹤0.01% | 3657 |
|